Navigation Links
Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing
Date:2/23/2010

ROCKVILLE, Md., Feb. 23 /PRNewswire/ -- STB Lifesaving Technologies® announced today $2.4 million was included in the FY2010 U.S. Department of Defense appropriations bill to advance the development of the Fibrin Adhesive STat (FAST®) dressing. This newly developed dressing is designed to be effective against all kinds of blood loss, including severe arterial and venous bleeding and could help save the lives of soldiers suffering from severe blood loss.

According to the Combat Casualty Care Research Program, eighty-six percent of combat-related deaths occur within 30 minutes of wounding, and fifty percent or more are attributable to uncontrolled hemorrhaging.  With better products to control bleeding, such as the STB FAST® dressing, thousands of military and civilian lives could be saved.

"We are grateful for Senator Cardin's continued support for STB® and honored by the opportunity to serve the Department of Defense. If awarded to STB®, these funds, along with funds provided by our investors, will be used to accelerate the step up to cGMP manufacturing, and the necessary planning and pre-clinical work required to file for approval by the FDA to initiate human clinical trials," said Ron Peele, STB®'s President.  

Much of the clinical planning will involve advisors from the University of Maryland and MD Shock Trauma Center, who will also be involved in the in vivo efficacy testing, which will be conducted at a facility in Reisterstown, MD.

About STB®  

Founded in 2005, STB Lifesaving Technologies® (STB®) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland. STB® which stands for "stop the bleeding", is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural protein technology with five patents and one provisional patent pending, STB®'s products will be indispensable to both the military and civilian medical markets.

SOURCE STB Lifesaving Technologies

Back to top

RELATED LINKS
http://www.stblifesaving.com

'/>"/>

SOURCE STB Lifesaving Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
3. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
4. Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications
5. U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain
6. Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan
7. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
8. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
9. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
10. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
11. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... and Markets has announced the addition of the "Active Pharmaceutical ... The global active pharmaceutical ingredients (API) market is ... The rising prevalence of lifestyle-induced & age-related diseases and cancer is ... recombinant molecular technologies and high capitalization for development of novel drugs ...
(Date:2/28/2017)... SINGAPORE and SAN FRANCISCO , February 27, 2017 ... four Se D ... portfolio of biotechnology assets   LOI contemplates capital ... term growth plan for building shareholder value   Amarantus names ... interim-CFO of Amarantus   SeD Biomedical Inc. ...
(Date:2/28/2017)... February 28, 2017 The global  pulse oximeters market  is ... by Grand View Research, Inc. The pulse oximeters market is anticipated to witness ... prevalence of target diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, ... ... Grand View Research Logo ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... February 28, 2017 , ... ... in North America for the scientific development, healthcare training and clinical application of ... & Scientific Session on September 16-17 in Greenville, SC at the Bon Secours ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... Las Vegas ... revamped South Rancho location on Friday, March 10, 2017, 4-7 pm PST. For more ... but this clinic, located in the South Rancho neighborhood, has been renovated to provide ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... BrightStar Care ... of Choice Awards from Home Care Pulse. This award is granted only to top-ranking ... BrightStar Care Marietta is now ranked among home care providers from across the ...
(Date:2/27/2017)... ... 2017 , ... Bo Chen, PhD is the recipient of the 2017 ASLMS ... the Plenary Session at ASLMS 2017, the Annual Conference of the American Society for ... 5-9, 2017. , During the Plenary Session on April 7, Dr. Chen will ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Robert E. Burke, ... medical group. But his impoverished upbringing and life experiences could have led him down ... Physician: Insightful and Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a ...
Breaking Medicine News(10 mins):